ArticleBMC pulmonary medicine2025

Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON).

Wim A Wuyts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.